{"id":"W4415619201","doi":"10.51731/cjht.2025.1265","title":"Elafibranor (Iqirvo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ursodeoxycholic acid; Reimbursement; Drug; Clinical trial; Compassionate Use; Clinical Practice","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009970526,0.0002326396,0.000545399,0.001209493,0.0002511138,0.0008904549,0.0004059728,0.0004617497,0.008787178],"category_scores_gemma":[0.001661966,0.00007941556,0.0007007458,0.0009596175,0.0002143122,0.0004270646,0.0002808786,0.0006009813,0.001169441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001585443,"about_ca_system_score_gemma":0.001916563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01794993,"about_ca_topic_score_gemma":0.05939011,"domain_scores_codex":[0.999387,0.0001355222,0.00007748276,0.00006176257,0.0002729996,0.00006534441],"domain_scores_gemma":[0.9994138,0.0001828804,0.0001682041,0.00001452208,0.0001773033,0.00004328586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008152951,0.00006339386,0.0007243979,0.008776667,0.0002672496,0.0001338326,0.00004872467,0.0001503056,0.002344736,0.002039815,0.02488715,0.9597483],"study_design_scores_gemma":[0.000653917,0.0007956617,0.006159076,0.008187467,0.0009753511,0.001100693,0.0000878132,0.0001225726,0.00261981,0.0006191698,0.9786542,0.00002422911],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.006120431,0.959703,0.0006019133,0.002249191,0.0002709413,0.0001056597,0.001277116,0.00008813508,0.02958364],"genre_scores_gemma":[0.1166269,0.8515269,0.003468661,0.004048586,0.0004002016,0.0001640267,0.002128458,0.00002341759,0.02161286],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01794993,"threshold_uncertainty_score":0.0356909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01866553383966691,"score_gpt":0.2979552200978029,"score_spread":0.279289686258136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}